Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

FibroGen Shares Climb On Strong Q1 Sales

By Erica Kollmann
May 7, 1:10 PM
FibroGen reported quarterly losses of 33 cents per share which missed the analyst consensus estimate of $(0.31) and represents a 59.26% increase year-over-year. Quarterly sales clocked in at $55.902 million which beat the analyst consensus estimate of $36.666 million by 52.46% and is a significant increase over sales of $36.161 million from the same period last year.

FGEN

Read More
2 minute read

Blade Air Mobility Takes Off: Beats on Q1 Revenue, Medical Soars, Reaffirms 2024 Outlook

By Lekha Gupta
May 7, 1:07 PM
Blade Air Mobility reported Q1 FY24 revenue of $51.5M, beating consensus of $49.5M. Short Distance revenue down due to weather, adjusted EBITDA loss improved. EPS loss exceeded estimate. Medical segment's EBITDA rose, net loss decreased. 2024 outlook reiterated, 2025 expects double-digit revenue and EBITDA growth.

ARKQ

Read More
1 minute read

Cereal Maker WK Kellogg Sticks To Annual Outlook Post Q1 Beat: Details

By Shivani Kumaresan
May 7, 11:57 AM
WK Kellogg exceeds expectations in Q1 FY24 with a 1.9% sales dip, reporting $707 million, surpassing analyst forecasts. Operating income surges 91.6% to $46 million, while adjusted EBITDA climbs 8.7% to $75 million. Chairman Gary Pilnick reaffirms strategic focus, projecting FY24 net sales growth of -1% to +1% and adjusted EBITDA growth of 3% to 5%, aiming for $265 million to $270 million.

KLG